Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors
Angiotensin converting enzyme 2 (ACE2) downregulation is a key negative factor for the severity of lung edema and acute lung failure observed in patients infected with SARS-CoV-2. ACE2 downregulation affects the levels of diverse peptide mediators of the renin-agiotensin-aldestosterone and kallikrei...
Saved in:
Main Authors: | Bahareh Rasaeifar (Author), Patricia Gomez-Gutierrez (Author), Juan J. Perez (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist
by: Anne Lesage, et al.
Published: (2020) -
New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding
by: Bahareh Rasaeifar, et al.
Published: (2020) -
Small-molecule CGRP receptor antagonists: A new approach to the acute and preventive treatment of migraine
by: David Moreno-Ajona, et al.
Published: (2020) -
A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors
by: Joseph Lau, et al.
Published: (2020) -
Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
by: Carlo Matera, et al.
Published: (2023)